Home › Cardiovascular Disease › Nebraska
Cardiovascular Disease clinical trials in Nebraska
9 studies for Cardiovascular Disease are looking for participants at sites in Nebraska.
Cities in Nebraska
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Fremont
- Clinical Trial Site, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07181109EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Methodist Physicians Clinic, Fremont
- Quality Clinical Research - Omaha, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07064473Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06526195Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- CHI Health Nebraska Heart, Grand Island
- Bryan Heart, Lincoln
- CHI Health Nebraska Heart, Lincoln
- and 1 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06909565Product Surveillance Registry
- Omaha
RecruitingObservational study
All ages · All sexes · Updated Oct 20, 2026 · NCT01524276CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT05931276Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- University of Nebraska Medical Center, Omaha
- Omaha VA Medical Center, Omaha
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Elkhorn
- Research Site, Fremont
- Research Site, Omaha
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Bryan Heart, Lincoln
- Physician Research Collaboration, LLC, Lincoln
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.